$SNSS SUNESIS PHARMACEUTICALS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in SUNESIS PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in SUNESIS PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in SUNESIS PHARMACEUTICALS INC for free.

CIK Number: 0001061027
IRS Number: 943295878
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SNSS
Company Address: 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO 94080
Phone number: 650-266-3500
Former name: MOSAIC PHARMACEUTICALS INC, date of change: 1998-07-09

Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.

Market Capitalization: $85.18M
Prev close: $4.10
Average Daily Volume: 44,423
Days Low: $4.05
Year Low: $2.63
Year High: $6.30

SUNESIS PHARMACEUTICALS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Fox Judith A.See Remarks00Apr 02 20204 days ago
Misfeldt DaytonInterim CEO1,598,2606,552,866shares bought: 400,000 / shares sold: 0 STRONG BUYApr 02 20204 days ago
Quinn William P.See Remarks121,697498,958shares bought: 115,697 / shares sold: 0 STRONG BUYApr 02 20204 days ago

View all SUNESIS PHARMACEUTICALS INC insiders.

SUNESIS PHARMACEUTICALS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 02 2020SNSSSUNESIS PHARMACEUT ...Quinn William P.See RemarksOption ExerciseA0.41360,000149,364360,000
Apr 02 2020SNSSSUNESIS PHARMACEUT ...Quinn William P.See RemarksBuyP0.376,0002,193127,697121.7 K to 127.7 K (+4.93 %)
Apr 02 2020SNSSSUNESIS PHARMACEUT ...Quinn William P.See RemarksBuyP0.656,0003,877121,697115.7 K to 121.7 K (+5.19 %)
Apr 02 2020SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonInterim CEOOption ExerciseA0.41480,000199,152480,000
Apr 02 2020SNSSSUNESIS PHARMACEUT ...Fox Judith A.See RemarksOption ExerciseA0.41457,500189,817457,500
Oct 01 2019SNSSSUNESIS PHARMACEUT ...ONETTO NICOLEDirectorOption ExerciseA0.7290,00064,79190,000
Aug 12 2019SNSSSUNESIS PHARMACEUT ...Fox Judith A.See RemarksOption ExerciseA0.8615,00012,90015,000
Jul 15 2019SNSSSUNESIS PHARMACEUT ...Aisling Capital IV, LP10% OwnerBuyP0.602,500,0001,500,00010,100,0007.6 M to 10.1 M (+32.89 %)
Jul 02 2019SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonInterim CEOOption ExerciseA0.73480,000348,864480,000
Jul 02 2019SNSSSUNESIS PHARMACEUT ...Misfeldt DaytonInterim CEOOption ExerciseA0.7360,00043,60860,000
Jul 02 2019SNSSSUNESIS PHARMACEUT ...YOUNG JAMES WDirectorOption ExerciseA0.7360,00043,60860,000
Jul 02 2019SNSSSUNESIS PHARMACEUT ...Carchedi SteveDirectorOption ExerciseA0.7360,00043,60860,000
Jul 02 2019SNSSSUNESIS PHARMACEUT ...Ketchum Steven BDirectorOption ExerciseA0.7360,00043,60860,000
Jul 02 2019SNSSSUNESIS PHARMACEUT ...STUMP DAVID CDirectorOption ExerciseA0.7360,00043,60860,000
Jul 02 2019SNSSSUNESIS PHARMACEUT ...Wolff Henry WardDirectorOption ExerciseA0.7360,00043,60860,000

View all SUNESIS PHARMACEUTICALS INC insider transactions.